Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC).
- Disclosed ownership: 9.6%.
- Date of event: 30 Sep 2024.
Nantahala Capital Management, LLC - 30 Sep 2024 SCHEDULE 13G Report for Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC)
- Filing Manager
- Nantahala Capital Management, LLC
- Reporting Manager
- Nantahala Capital Management, LLC
- Symbol
- BNTC
- Shares outstanding
- 10,755,974 shares
- Disclosed Ownership
- 1,038,371 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Nov 2024, 16:53:53 UTC
- Date of event
- 30 Sep 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 9.6% ownership in Benitec Biopharma Inc. Common Stock, par value $0.0001 (BNTC) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Nov 2024, 16:53.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.7% | 1,038,371 | 0 | 1,038,371 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 9.7% | 1,038,371 | 0 | 1,038,371 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 9.7% | 1,038,371 | 0 | 1,038,371 | /s/ Daniel Mack | Daniel Mack |